Following 4 weeks of IFN-α treatment, we find that the number of modulated genes is more than seven times larger in patients who develop depression than in patients who do not, suggesting that patients who develop IFN-α-induced depression have an increased biological sensitivity to IFN-α. This evidence concerns the gene IFNA1 and depressive symptom measurement.